Physician profile
Daniel J Warner
NPI 1457562480
$2,736.45
in general payments reported to CMS, 2019-2025
29 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $276 · 2021: $189 · 2022: $823 · 2023: $333 · 2024: $370 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $982.41 | 2019-2023 | Biobrace 23mm |
| Viiv Healthcare Company | $471.76 | 2023-2025 | Cabenuva, Dovato, Apretude |
| Ferring Pharmaceuticals INC. | $172.99 | 2019-2023 | Euflexxa |
| Bioventus LLC | $152.47 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Dynasplint Systems INC. | $105.82 | 2020 | |
| Stryker Corporation | $96.28 | 2019-2023 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid |
| Zimmer Biomet Holdings, INC. | $74.13 | 2024 | Affixus |
| Pacira Therapeutics, INC. | $63.33 | 2019-2021 | |
| Smith+Nephew, INC. | $54.56 | 2020-2025 | Collagenase Santyl |
| Ermi LLC | $47.02 | 2020-2021 | |
| Depuy Synthes Sales INC. | $46.36 | 2019-2021 | |
| Heron Therapeutics, INC. | $46.02 | 2022 | |
| Abbott Laboratories | $44.41 | 2019-2021 | |
| Integra Lifesciences Corporation | $40.92 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| C. R. Bard, INC. & Subsidiaries | $40.56 | 2023 | Arista Ah Flexitip |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $40.47 | 2020 | |
| Sanofi-Aventis U.S. LLC | $37.56 | 2021-2023 | |
| Kerecis Limited | $28.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Biocomposites INC | $23.85 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.96 | 2024 | Zilretta, Iovera |
| Amgen INC. | $19.13 | 2025 | Krystexxa |
| Fidia Pharma USA INC. | $17.80 | 2019-2021 | |
| Medtronic, INC. | $17.40 | 2024 | Intellis Adaptivestim |
| Endo Pharmaceuticals INC. | $16.68 | 2021 | |
| Kci USA, INC. | $15.90 | 2019 | |
| Osteomed LLC | $15.74 | 2019 | |
| Supreme Orthopedic Systems, LLC | $15.47 | 2024 | |
| Orthofix Medical, INC. | $13.41 | 2024 | Physio-Stim, Accelstim |
| Wright Medical Technology, INC. | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.